← Eichor
Condition: Malignant Ovarian Epithelial Tumor Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Malignant Ovarian Epithelial Tumor

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With
Phase 2 · 1 location(s) · Northwestern University · NCT05733000ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer
Phase 2 · 2 location(s) · Ira Winer · NCT04055649Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel i
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT05092373DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cance
Phase 2/Phase 3 · 16 location(s) · Cancer Research UK · NCT05768178A Study of NX-1607 in Adults With Advanced Malignancies
Phase 1 · 17 location(s) · Nurix Therapeutics, Inc. · NCT05107674Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
Phase 1 · 3 location(s) · BioEclipse Therapeutics · NCT04282044The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Tr
Phase 2 · 1 location(s) · Mayo Clinic · NCT07285044Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT01950572Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
Phase N/A · 1 location(s) · Northwestern University · NCT00005095CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors
Phase 1 · 1 location(s) · Chongqing Precision Biotech Co., Ltd · NCT07181720Biomarkers of Resiliency In Childhood Cancer Surgery
Phase N/A · 1 location(s) · Mayo Clinic · NCT06674811CT-95 in Advanced Cancers Associated With Mesothelin Expression
Phase 1 · 9 location(s) · Context Therapeutics Inc. · NCT06756035IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT05039801The Vanguard Study: Testing a New Way to Screen for Cancer
NA · 39 location(s) · National Cancer Institute (NCI) · NCT06995898Identifying and Caring for Individuals With Inherited Cancer Syndrome
NA · 2 location(s) · OHSU Knight Cancer Institute · NCT04494945Study of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors
Phase 1 · 6 location(s) · Myeloid Therapeutics · NCT05969041Clinical Study on the Re-irradiation of Lateral Pelvic Recurrences of Gynecological Malignancies
NA · 1 location(s) · CNAO National Center of Oncological Hadrontherapy · NCT05457595A Beta-only IL-2 ImmunoTherapY Study
Phase 1/Phase 2 · 27 location(s) · Medicenna Therapeutics, Inc. · NCT05086692A Study of DEG6498 in Participants With Solid Tumors
Phase 1 · 3 location(s) · Degron Therapeutics Co. · NCT07244835Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Associated With Systemic Chemotherapy in Women With Advanced Ov
Phase 1 · 6 location(s) · Hospices Civils de Lyon · NCT04811703A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors
Phase 1/Phase 2 · 12 location(s) · A2 Biotherapeutics Inc. · NCT06051695Fertility-sparing Therapy for Patients With Stage IA Endometrial Cancer
NA · 1 location(s) · Peking University People's Hospital · NCT05945407Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Phase 1 · 17 location(s) · SystImmune Inc. · NCT06293898Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Phase N/A · 16 location(s) · A2 Biotherapeutics Inc. · NCT04981119Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Phase 1/Phase 2 · 21 location(s) · Children's Oncology Group · NCT04851119Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Phase N/A · 745 location(s) · Alliance for Clinical Trials in Oncology · NCT05334069Clinical Application of PET Imaging Targeting MSLN in Malignant Tumors
Phase N/A · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT06843629Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors
Phase N/A · 2 location(s) · University of Southern California · NCT07259304INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TU
NA · 2 location(s) · Azienda Ospedaliero-Universitaria di Parma · NCT07403630DBC-664 in Adult Patients With Solid Tumors
Phase 1 · 3 location(s) · Duboce Biopharmaceuticals, Inc. · NCT07705035
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.